IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Patient Square Capital LP

Q1 2026 Holdings

Filed 2026-05-15 | 29 holdings | $563.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Roivant Sciences LTD(ROIV)SHSG76279101$226.2M8,166,04740.1%
Argenx SE(ARGX)SPONSORED ADR04016X101$26.8M36,7184.8%
Insmed Inc(INSM)COM PAR $.01457669307$25.8M157,5004.6%
Beone Medicines LTD(ONC)SPONSORED ADS07725L102$23.9M80,5424.2%
Cogent Biosciences Inc(COGT)COM19240Q201$22.9M596,0004.1%
Mirum Pharmaceuticals Inc(MIRM)COM604749101$21.2M230,0003.8%
Belite BIO Inc(BLTE)SPONSORED ADS07782B104$18.6M116,6843.3%
Legend Biotech Corp(LEGN)SPONSORED ADS52490G102$17.9M990,0003.2%
Nektar Therapeutics(NKTR)COM NEW640268306$15.1M210,0002.7%
DBV Technologies S A(DBVT)SPONSORED ADS23306J309$14.5M693,5342.6%
Pharvaris N V(PHVS)COMN69605108$13.9M493,0002.5%
Abivax SA(ABVX)SPONSORED ADS00370M103$13.5M121,2452.4%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$13.2M227,0002.3%
Celcuity Inc(CELC)COM15102K100$10.8M95,0001.9%
Eyepoint Inc(EYPT)COM NEW30233G209$10.2M795,0001.8%
Merck & Co Inc(MRK)COM58933Y105$9.6M80,0001.7%
Arcutis Biotherapeutics Inc(ARQT)COM03969K108$9.4M400,6451.7%
Allogene Therapeutics Inc(ALLO)COM019770106$8.4M3,450,0001.5%
Kymera Therapeutics Inc(KYMR)COM501575104$8.3M100,0001.5%
Dianthus Therapeutics Inc(DNTH)COM252828108$7.9M93,8821.4%
Enliven Therapeutics Inc(ELVN)COM29337E102$7.8M200,0001.4%
Perspective Therapeutics Inc(CATX)COM NEW46489V302$6.8M1,625,0001.2%
Definium Therapeutics Inc(DFTX)COM SHS24477V105$6.3M331,0001.1%
Harrow Inc(HROW)COM415858109$5.8M165,2091.0%
Protara Therapeutics Inc(TARA)COM STK74365U107$5.4M1,030,8461.0%
Cytomx Therapeutics Inc.(CTMX)COM23284F105$5.1M1,085,7900.9%
Arcus Biosciences Inc(RCUS)COM03969F109$4.2M195,0000.7%
Assembly Biosciences Inc(ASMB)COM NEW045396207$3.8M136,3150.7%
Spyre Therapeutics Inc(SYRE)COM NEW00773J202$50.4K1,0000.0%